Features of Lung Cancer Treatment–Related AML
Therapy-related AML after lung cancer is rare, but is associated with poor prognosis.
Daily Oncology News
Simple Flow-Based Prognostic Score Developed for Patients With MDS
Although other flow cytometry–based prognostic scores have been proposed in the setting of MDS, their complexity has limited their clinical use.
Cardiomyopathy Screenings Low Among Young Cancer Survivors Exposed to Chest Radiation or Anthracyclines
Electronic medical records for more than 3500 survivors of pediatric malignancies were reviewed to determine number for whom cardiomyopathy screenings were recommended and rate of compliance with that recommendation.
Increased Mortality Risk in Patients With Cancer Experiencing the Death of a Child
Population-based study evaluated survival outcomes for patients with cancer diagnosed over a 41-year period.
Risk Factors for Early Relapse of DLBCL After CAR-T Therapy
Nearly half of all relapses occurred within the first month of CAR-T infusion.
HCT Deemed More Favorable for MDS That Is High Risk
HCT resulted in a lower risk of death among patients with high risk disease or if performed shortly after diagnosis, according to an observational study.
Grants Awarded to Help VA Centers Enroll Veterans Into Cancer Trials
Two VA medical centers were each awarded one-time $50,000 grant funding to help them enroll veterans with cancer into clinical trials.
Chemotherapy-Free Combination Therapy Targeted to the Epigenome in PTCL
Peripheral T-cell lymphoma is characterized by extensive epigenetic dysregulation.
Venous Thromboembolism Risk Steadily Increasing in Cancer
The risk for venous thromboembolism is steadily increasing among patients with cancer compared with the general population.
Medicaid Expansion Tied to Increased Detection of Early Cancers
Three years after expansion, a decrease in late-stage cancers was also detectable.
Does Type of Radiation Therapy in Hodgkin Lymphoma Treatment Affect Lung Toxicity?
Researchers examined data from patients who were treated for Hodgkin lymphoma between 2009 and 2013 who had received radiation therapy as part of their treatment.
Conditioning With Alkylating Agents Prior to Transplant for Myelofibrosis
Patients with myelofibrosis conditioned with 2 alkylating agents may have better transplant outcomes compared with patients receiving 1 alkylating agent.
U.S. COVID-19 Deaths Top a Quarter Million
COVID-19 cases on the rise in all but one state.
New Dosing Option Approved for Imfinzi in NSCLC, Bladder Cancer
The approval was based on data from several clinical trials, including the phase 3 PACIFIC trial and the phase 3 CASPIAN trial.
Lorlatinib Superior to Crizotinib for ALK-Positive NSCLC
Interim analysis shows risk for disease progression or death lower for first-line therapy with lorlatinib versus crizotinib.
Skin Cancer Clinical Trials
Clinical Trial: The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Clinical trial focusing on herditary nonpolyposis colon cancer. The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC)
Clinical Trial: Spectral Diagnosis of Cutaneous Malignancy
Clinical trial focusing on spectral diagnosis. Spectral Diagnosis of Cutaneous Malignancy
Clinical Trial: Electronic Brachytherapy for the Treatment of NMSC
Clinical trial focusing on electronic brachytherapy. Electronic Brachytherapy for the Treatment of NMSC
Clinical Trial: Use of the Epidermal Micrografts for Wound Healing After Mohs or Excisional Surgery for Skin Cancer
Clinical trial focusing on epidermal micrografts. Use of the Epidermal Micrografts for Wound Healing After Mohs or Excisional Surgery for Skin Cancer
Clinical Trial: Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project
Clinical trial focusing on Mohs surgery project. Experience of Non-Melanoma Skin Cancer (NMSC) Mohs Surgery Project
-
Loading...
-
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Daily Oncology News
